Back to Journals » Clinical Epidemiology » Volume 5 » Issue 1
Review
The NordiNet® International Outcome Study and NovoNet® ANSWER Program®: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin®)
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,746 | Dovepress* | 13,682+ | 2,210 | 15,892 | |
PubMed Central* | 5,064 | 1,072 | 6,136 | ||
Totals | 18,746 | 3,282 | 22,028 | ||
*Since 26 April 2013 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar